Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Once-daily versus twice-daily timolol eye drops for open-angle glaucoma
PACTR202412559535575Completed
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of timolol in open-angle glaucoma (OAG) (2 arms). Primary endpoint: Intraocular pressure. Started Jul 2022; status: completed.
02
Drugs
timolol
03
Conditions
open-angle glaucoma (OAG)
Beyond the preview
Go deeper on PACTR202412559535575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202412559535575.